Home/Filings/4/0000921895-18-001764
4//SEC Filing

Perelman Vadim 4

Accession 0000921895-18-001764

CIK 0001040719other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 7:31 PM ET

Size

23.2 KB

Accession

0000921895-18-001764

Insider Transaction Report

Form 4
Period: 2018-05-15
Transactions
  • Sale

    Common Stock

    2018-05-15$6.27/sh25,000$156,750391,842 total(indirect: By: Baker Street Capital L.P.)
Holdings
  • Common Stock

    7,314
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,461 underlying)
    12,461
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,171 underlying)
    710,171
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
  • Common Stock

    (indirect: By: Baskerville SPV, L.P.)
    76,897
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,887 underlying)
    9,887
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,506 underlying)
    563,506
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,008 underlying)
    131,008
Transactions
  • Sale

    Common Stock

    2018-05-15$6.27/sh25,000$156,750391,842 total(indirect: By: Baker Street Capital L.P.)
Holdings
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,461 underlying)
    12,461
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,887 underlying)
    9,887
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,008 underlying)
    131,008
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,171 underlying)
    710,171
  • Common Stock

    7,314
  • Common Stock

    (indirect: By: Baskerville SPV, L.P.)
    76,897
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,506 underlying)
    563,506
Transactions
  • Sale

    Common Stock

    2018-05-15$6.27/sh25,000$156,750391,842 total(indirect: By: Baker Street Capital L.P.)
Holdings
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,461 underlying)
    12,461
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,506 underlying)
    563,506
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,887 underlying)
    9,887
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,171 underlying)
    710,171
  • Common Stock

    7,314
  • Common Stock

    (indirect: By: Baskerville SPV, L.P.)
    76,897
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,008 underlying)
    131,008
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
Transactions
  • Sale

    Common Stock

    2018-05-15$6.27/sh25,000$156,750391,842 total(indirect: By: Baker Street Capital L.P.)
Holdings
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,171 underlying)
    710,171
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,008 underlying)
    131,008
  • Common Stock

    7,314
  • Common Stock

    (indirect: By: Baskerville SPV, L.P.)
    76,897
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,887 underlying)
    9,887
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,461 underlying)
    12,461
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,506 underlying)
    563,506
Transactions
  • Sale

    Common Stock

    2018-05-15$6.27/sh25,000$156,750391,842 total(indirect: By: Baker Street Capital L.P.)
Holdings
  • Common Stock

    7,314
  • Common Stock

    (indirect: By: Baskerville SPV, L.P.)
    76,897
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,461 underlying)
    12,461
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,506 underlying)
    563,506
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,008 underlying)
    131,008
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,887 underlying)
    9,887
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,171 underlying)
    710,171
Footnotes (3)
  • [F1]This Form 4 is filed jointly by Baker Street Capital L.P. ("BSC LP"), Baskerville SPV, L.P. ("Baskerville SPV"), Baker Street Capital GP, LLC ("BSC GP"), Baker Street Capital Management, LLC ("Baker Street Capital Management") and Vadim Perelman (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such shares of Common Stock for purposes of Section 16 or for any other purpose.
  • [F2]Represents securities owned directly by BSC LP. BSC GP, as the general partner of BSC LP, may be deemed to beneficially own the securities owned by BSC LP. Baker Street Capital Management, as the investment manager of BSC LP, may be deemed to beneficially own the securities owned by BSC LP. Mr. Perelman, as the managing member of each of BSC GP and Baker Street Capital Management, may be deemed to beneficially own the securities owned by BSC LP.
  • [F3]Represents securities owned directly by Baskerville SPV. BSC GP, as the general partner of Baskerville SPV, may be deemed to beneficially own the securities owned by Baskerville SPV. Baker Street Capital Management, as the investment manager of Baskerville SPV, may be deemed to beneficially own the securities owned by Baskerville SPV. Mr. Perelman, as the managing member of each of BSC GP and Baker Street Capital Management, may be deemed to beneficially own the securities owned by Baskerville SPV.

Issuer

DITECH HOLDING Corp

CIK 0001040719

Entity typeother

Related Parties

1
  • filerCIK 0001489810

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 7:31 PM ET
Size
23.2 KB